Early stage non-small cell lung cancer patients need brain imaging regardless of symptoms

Background Japanese Lung Cancer Society and ESMO guideline recommends screening for brain metastasis in all patients with non-small cell lung cancer (NSCLC), while NCCN/ACCP guidelines do not recommend screening patients who are asymptomatic and with clinical stage I NSCLC. However, brain metastasis...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of clinical oncology 2018-08, Vol.23 (4), p.641-646
Hauptverfasser:	Ando, Takahiro, Kage, Hidenori, Saito, Minako, Amano, Yosuke, Goto, Yasushi, Nakajima, Jun, Nagase, Takahide
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma Adenocarcinoma - diagnostic imaging Adenocarcinoma - genetics Adenocarcinoma - secondary Adult Aged Aged, 80 and over Brain cancer Brain Neoplasms - diagnostic imaging Brain Neoplasms - genetics Brain Neoplasms - secondary Cancer Research Carcinoma, Non-Small-Cell Lung - diagnostic imaging Carcinoma, Non-Small-Cell Lung - genetics Carcinoma, Non-Small-Cell Lung - secondary Carcinoma, Squamous Cell - diagnostic imaging Carcinoma, Squamous Cell - genetics Carcinoma, Squamous Cell - secondary Central nervous system Epidermal growth factor receptors ErbB Receptors - genetics Female Humans Lung cancer Lung Neoplasms - diagnostic imaging Lung Neoplasms - genetics Lung Neoplasms - pathology Male Medical imaging Medical records Medicine Medicine & Public Health Metastases Metastasis Middle Aged Mutation Nervous system Neuroimaging Neuroimaging - methods Non-small cell lung carcinoma Oncology Original Article Prognosis Retrospective Studies Surgical Oncology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!